- Home
- ORGO vs SIGA Comparison
ORGO vs SIGA Comparison
Compare ORGO & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- SIGA
- Stock Information
- Founded
- ORGO 1985
- SIGA 1995
- Country
- ORGO United States
- SIGA United States
- Employees
- ORGO N/A
- SIGA N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- ORGO Health Care
- SIGA Health Care
- Exchange
- ORGO Nasdaq
- SIGA Nasdaq
- Market Cap
- ORGO 459.5M
- SIGA 443.4M
- IPO Year
- ORGO N/A
- SIGA 1997
- Fundamental
- Price
- ORGO $3.21
- SIGA $5.91
- Analyst Decision
- ORGO Strong Buy
- SIGA
- Analyst Count
- ORGO 2
- SIGA 0
- Target Price
- ORGO $5.00
- SIGA N/A
- AVG Volume (30 Days)
- ORGO 387.6K
- SIGA 401.8K
- Earning Date
- ORGO 02-27-2025
- SIGA 03-11-2025
- Dividend Yield
- ORGO N/A
- SIGA 10.16%
- EPS Growth
- ORGO N/A
- SIGA N/A
- EPS
- ORGO N/A
- SIGA 1.20
- Revenue
- ORGO $455,038,000.00
- SIGA $173,731,386.00
- Revenue This Year
- ORGO $9.65
- SIGA $16.79
- Revenue Next Year
- ORGO $1.57
- SIGA $15.08
- P/E Ratio
- ORGO N/A
- SIGA $4.94
- Revenue Growth
- ORGO 1.34
- SIGA 399.31
- 52 Week Low
- ORGO $2.17
- SIGA $4.75
- 52 Week High
- ORGO $4.57
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- ORGO 38.78
- SIGA 43.23
- Support Level
- ORGO $3.42
- SIGA $5.80
- Resistance Level
- ORGO $3.78
- SIGA $6.25
- Average True Range (ATR)
- ORGO 0.15
- SIGA 0.23
- MACD
- ORGO -0.04
- SIGA 0.01
- Stochastic Oscillator
- ORGO 1.72
- SIGA 43.44
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.